Helena M Verkooijen Selected Research

Helena M Verkooijen Research Topics

Disease

40	Breast Neoplasms (Breast Cancer) 03/2022 - 07/2005
37	Neoplasms (Cancer) 03/2022 - 07/2005
20	Neoplasm Metastasis (Metastasis) 10/2022 - 09/2012
10	Rectal Neoplasms (Rectal Cancer) 01/2022 - 09/2008
10	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2007
10	Pain (Aches) 03/2021 - 09/2012
7	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 11/2013
4	COVID-19 02/2022 - 02/2021
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 10/2022 - 09/2008
2	Erectile Dysfunction 10/2021 - 01/2018
2	Mastodynia 09/2021 - 06/2019
2	Seroma 11/2014 - 02/2014
1	Coronary Disease (Coronary Heart Disease) 09/2022
1	Inflammation (Inflammations) 03/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Diabetes Mellitus 01/2021
1	Edema (Dropsy) 06/2019
1	Urinary Incontinence 01/2018
1	AIDS-Related Complex (ARC) 10/2016
1	Triple Negative Breast Neoplasms 11/2015
1	Esophageal Neoplasms (Esophageal Cancer) 01/2015
1	Vascular Calcification 01/2015
1	Anastomotic Leak 01/2015
1	Spinal Diseases (Disease, Spinal) 12/2014
1	Liver Diseases (Liver Disease) 09/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2014
1	Leiomyomatosis 11/2013
1	Leiomyoma (Uterine Fibroids) 11/2013
1	Hyperthyroidism 06/2013
1	Hepatocellular Carcinoma (Hepatoma) 08/2012
1	Lymphatic Metastasis 01/2012
1	Hemorrhage 12/2011
1	Infections 12/2011
1	Wounds and Injuries (Trauma) 12/2011
1	Lung Neoplasms (Lung Cancer) 03/2011
1	Circulating Neoplastic Cells 12/2009
1	Second Primary Neoplasms (Neoplasms, Second) 09/2008

Drug/Important Bio-Agent (IBA)

5	Estrogen ReceptorsIBA 02/2015 - 07/2005
5	Hormones (Hormone)IBA 08/2014 - 10/2007
3	CalciumIBA 09/2022 - 01/2016
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 04/2021 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 11/2017 - 01/2014
2	IodineIBA 06/2013 - 02/2003
2	Biomarkers (Surrogate Marker)IBA 05/2012 - 12/2009
2	Estrogens (Estrogen)FDA Link 05/2011 - 03/2011
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2022
1	SuspensionsIBA 10/2021
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	AnthracyclinesIBA 01/2019
1	mesoglycanIBA 04/2018
1	Holmium-166IBA 10/2016
1	Iodine-125IBA 01/2016
1	RacivirIBA 11/2014
1	TabletsIBA 10/2014
1	gadolinium ethoxybenzyl DTPA FDA Link 09/2014
1	gadobutrolIBA 09/2014
1	Contrast MediaIBA 09/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 08/2014
1	Angiotensin IIIBA 01/2014
1	IodidesIBA 06/2013
1	IsotopesIBA 08/2012
1	Pharmaceutical PreparationsIBA 08/2012
1	Yttrium-90IBA 08/2012
1	human ERBB2 proteinIBA 05/2012
1	exemestane (Aromasin)FDA Link 01/2012
1	Aromatase InhibitorsIBA 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2011
1	Dihydrotachysterol (AT 10)IBA 10/2007

Therapy/Procedure

53	Radiotherapy 06/2022 - 07/2005
12	Therapeutics 01/2022 - 01/2007
9	Neoadjuvant Therapy 01/2022 - 05/2011
8	Drug Therapy (Chemotherapy) 01/2021 - 11/2007
7	Segmental Mastectomy (Lumpectomy) 03/2022 - 01/2007
6	Aftercare (After-Treatment) 02/2022 - 11/2013
4	Palliative Care (Palliative Therapy) 06/2022 - 01/2014
4	Microspheres (Microsphere) 10/2016 - 08/2012
3	Particle Accelerators 01/2021 - 01/2017
3	Mastectomy (Mammectomy) 01/2018 - 11/2015
3	Catheters 10/2016 - 08/2012
3	Hormone Replacement Therapy (Therapy, Hormone Replacement) 04/2010 - 03/2006
2	Adjuvant Chemotherapy 10/2022 - 06/2019
2	Treatment Delay 10/2022 - 12/2020
2	Lymph Node Excision (Lymph Node Dissection) 06/2019 - 01/2014
2	Length of Stay 01/2019 - 03/2016
2	Radiofrequency Ablation 03/2017 - 01/2007
2	Ablation Techniques 11/2013 - 08/2011
1	Hyperbaric Oxygenation 09/2021
1	Organ Sparing Treatments 11/2020
1	Proctectomy 01/2018
1	High-Intensity Focused Ultrasound Ablation 03/2017
1	Brachytherapy 01/2016
1	Adjuvant Radiotherapy 11/2015
1	Esophagectomy 01/2015
1	Retreatment 12/2014
1	Re-Irradiation 09/2012
1	Liver Transplantation 08/2012
1	Chemoprevention 01/2012